Imaging system
US-12169175-B2 · Dec 17, 2024 · US
US2016135754A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016135754-A1 |
| Application number | US-201514939637-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 12, 2015 |
| Priority date | Nov 13, 2014 |
| Publication date | May 19, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A system and method for monitoring biological parameters in freely moving animals that, in the illustrative embodiment, comprises a two-color optical measurement/recording system that is combined with a fluorescent protein reporter of cellular membrane potentials and a fluorescent protein that is insensitive to such cellular membrane potentials. The two wavelengths are used to un-mix physiological artifacts in recordings that occur in freely moving animals.
Opening claim text (preview).
What is claimed: 1 . A method comprising: delivering, to a target tissue, excitation light having a first wavelength and a second wavelength, wherein the target tissue contains a sensor and a reference; collecting optical domain responses from the sensor and the reference, the response from the sensor includes information pertaining to a biological parameter of interest as well as information pertaining to physiological artifacts and the response from the reference includes information pertaining to the physiological artifacts but not the biological parameter; and extracting the information pertaining to the biological parameter free of physiological artifacts. 2 . The method of claim 1 wherein extracting a signal representative of a biological parameter further comprises unmixing the physiological artifacts from the response of the sensor using information contained in the response of the reference. 3 . The method of claim 1 wherein delivering excitation light further comprises generating first light having the first wavelength from a first light source and generating second light having the second wavelength from a second light source. 4 . The method of claim 3 and further comprising modulating the first light via a first modulation frequency. 5 . The method of claim 4 and further comprising modulating the second light via the first modulation frequency and shifting phase of the second light relative to the first light. 6 . The method of claim 3 and further comprising measuring the intensity of the first light and the second light. 7 . The method of claim 1 wherein delivering excitation light to target tissue further comprises propagating the excitation light to a waveguide that is in optical communication with the target tissue. 8 . The method of claim 7 wherein collecting optical domain responses from the sensor and the reference further comprises receiving the optical domain responses in the waveguide. 9 . The method of claim 1 and further comprising separating the optical domain responses from the sensor and the reference. 10 . The method of claim 1 and further comprising converting the optical domain responses from the sensor and the reference into electrical domain analogues thereof. 11 . The method of claim 1 wherein extracting the information further comprises: generating an estimate of hemodynamic artifacts present in the response from the sensor; and generating a linear unmixing matrix for sorting the biological parameter of interest from the physiological artifacts using the estimate of hemodynamic artifacts. 12 . The method of claim 11 wherein the linear unmixing matrix is generated using independent component analysis. 13 . The method of claim 1 wherein the sensor is a first fluorescent protein and the reference is a second fluorescent protein. 14 . The method of claim 1 wherein the biological parameter is membrane voltage of a neuron. 15 . The method of claim 1 and further comprising delivering the sensor and the reference to the target tissue. 16 . A system comprising: an excitation light subsystem, wherein the excitation light subsystem generates light having a first wavelength and a second wavelength, wherein the first wavelength is suitable for exciting fluorescence in a sensor, but not a reference, and the second wavelength is suitable for exciting fluorescence in the reference but not the sensor, and wherein fluorescence from the sensor contains information pertaining to a biological parameter of interest and physiological artifacts, including hemodynamic artifacts, and fluorescence from the reference contains information pertaining to the physiological artifacts, including hemodynamic artifacts, but not the biological parameter of interest; a waveguide for propagating the light to a target tissue and receiving fluorescence from the sensor and the reference; a signal processing subsystem comprising a processor that: (1) generates an estimate of hemodynamic artifacts; (2) extracts information pertaining to the biological parameter of interest free of any physiological artifacts by generating a linear unmixing matrix using the estimate of hemodynamic artifacts as an input. 17 . The system of claim 16 wherein the linear unmixing matrix is generated using independent component analysis. 18 . The system of claim 16 wherein the excitation light subsystem comprises a first laser for generating the light having the first wavelength and a second laser for generating the light having the second wavelength. 19 . A method comprising: delivering a fluorescent sensor protein to a target tissue, wherein the sensor protein is responsive to a membrane voltage, hemodynamic artifacts, and motion artifacts; delivering a fluorescent reference protein to the target tissue, wherein the reference protein is responsive to the hemodynamic artifacts and the motion artifacts but not to membrane voltage; delivering excitation light to the target tissue to cause the sensor protein and the reference protein to fluoresce; collecting the fluorescence from the sensor protein and the reference protein; separating the fluorescence from the sensor protein and the reference protein; converting the fluorescence from the sensor protein to a first electrical signal and the fluorescence for the reference protein to a second electrical signal; estimating the hemodynamic artifacts present in the first electrical signal; and extracting a signal indicative of membrane voltage, free of hemodynamic and motion artifacts, using the estimate of hemodynamic artifacts and independent component analysis. 20 . The method of claim 19 wherein the fluorescent sensor protein is MacQ-mCitrine and the fluorescent reference protein is mCherry.
by measuring fluorescence emission · CPC title
Animals · CPC title
Evaluating the brain (for intracranial pressure A61B5/031; for cerebral blood gases A61B5/14553; using EEG A61B5/369) · CPC title
the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo · CPC title
using a separate sensor to detect motion or using motion information derived from signals other than the physiological signal to be measured · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.